Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) para Mild Cognitive Impairment (MCI)

B

Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusión

Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.

Key Study Findings

Systematic Review n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None vs: Placebo or control Outcome: Cognitive function in AD and MCI patients Efecto: None None

Población: AD and MCI patients aged 50-90 (31 clinical trials)

Randomized Controlled Trial n=73 12 weeks Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily vs: IL triamcinolone acetonide alone Outcome: Hair density (regrowth scale) Efecto: None 0.018 (scalp subgroup at wk12)

Población: Patients with scalp and beard alopecia areata (179 patches)

Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None vs: None Outcome: Cognitive outcomes (memory, executive function) Efecto: None None

Población: Aging adults with cognitive impairment (review)

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Other
Milk Fat Globules: 2024 Updates.
Dose: None vs: None Outcome: Inflammatory markers Efecto: None None

Población: None

Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None vs: None Outcome: Cognitive function Efecto: None None

Población: Alzheimer's disease patients

Key Statistics

18

Estudios

3200

Participantes

Positive

B

Calificación

Referenced Papers

Newborn (Clarksville, Md.) 2024 9 citas
Current opinion in … 2023 58 citas
Nutrients 2022 76 citas
The Senior care … 2021 2 citas
Psychiatrike = Psychiatriki 2020 15 citas
Nutricion hospitalaria 2019 40 citas
Actas espanolas de … 2017 22 citas
European journal of … 2014 204 citas
Advances in nutrition … 2013 155 citas
Molecular neurobiology 2010 145 citas
Journal of Alzheimer's … 2010 110 citas
Women's health (London, … 2010 48 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Límite superior: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Mixed 3582
IL triamcinolone every 4 weeks + calcipotriol twice daily 12 weeks Positive 73
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --
Vitamin D3 vs triamcinolone acetonide 12 weeks Positive 40
None -- Positive --

Mejor momento para tomar: With meals containing fat for better absorption

Safety & Side Effects

Efectos secundarios reportados

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Interacciones conocidas

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Ingesta máxima tolerable: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.